Hunan Er-Kang Pharmaceutical Co., Ltd (SHE:300267)
3.110
-0.010 (-0.32%)
May 19, 2025, 2:45 PM CST
SHE:300267 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -348.16 | -373.37 | -195.32 | 45.94 | -791.2 | 192.31 | Upgrade
|
Depreciation & Amortization | 197.36 | 197.36 | 204.29 | 176.49 | 197.09 | 191.36 | Upgrade
|
Other Amortization | 3.45 | 3.45 | 7.81 | 5.28 | 2.26 | 0.9 | Upgrade
|
Loss (Gain) From Sale of Assets | -0.2 | -0.2 | -8.8 | -0.05 | -0.23 | -0.22 | Upgrade
|
Asset Writedown & Restructuring Costs | 237.41 | 237.41 | 12.91 | 0 | 703.18 | 2.55 | Upgrade
|
Loss (Gain) From Sale of Investments | 55.58 | 55.58 | 8.53 | -18.88 | -18.84 | -124.13 | Upgrade
|
Provision & Write-off of Bad Debts | -1.53 | -1.53 | 62.85 | 7.56 | -11.54 | 20.73 | Upgrade
|
Other Operating Activities | -18.86 | 21.2 | 29.46 | 1.73 | 208.2 | 36.13 | Upgrade
|
Change in Accounts Receivable | -21.89 | -21.89 | -19.96 | -9.11 | 125.94 | -189.5 | Upgrade
|
Change in Inventory | 66.64 | 66.64 | 46.97 | -111.76 | -161 | 57 | Upgrade
|
Change in Accounts Payable | -35.61 | -35.61 | 8.58 | 76.47 | 35.93 | -93.44 | Upgrade
|
Change in Other Net Operating Assets | 15.35 | 15.35 | -18.47 | 133.6 | -137.98 | 22.22 | Upgrade
|
Operating Cash Flow | 151.84 | 166.69 | 148.42 | 281.02 | 92.68 | 113.49 | Upgrade
|
Operating Cash Flow Growth | -46.22% | 12.31% | -47.19% | 203.20% | -18.33% | -74.54% | Upgrade
|
Capital Expenditures | -173.57 | -195.6 | -238.19 | -173.49 | -349.33 | -595.89 | Upgrade
|
Sale of Property, Plant & Equipment | 0.37 | 0.18 | 20.11 | 0.4 | 1.24 | 0.07 | Upgrade
|
Cash Acquisitions | - | - | - | - | -60.55 | -3.72 | Upgrade
|
Divestitures | - | - | - | 1.42 | 3.31 | 100.42 | Upgrade
|
Investment in Securities | 130 | -119.77 | 100.35 | -100 | 354.93 | -398 | Upgrade
|
Other Investing Activities | -4.96 | -6.97 | 12.81 | 13.09 | 17.22 | 19.49 | Upgrade
|
Investing Cash Flow | -48.15 | -322.15 | -104.92 | -258.58 | -33.18 | -877.63 | Upgrade
|
Short-Term Debt Issued | - | 546.08 | 341 | 376.75 | 396 | 820 | Upgrade
|
Total Debt Issued | 508.38 | 546.08 | 341 | 376.75 | 396 | 820 | Upgrade
|
Short-Term Debt Repaid | - | -401 | -380.13 | -246 | -613 | -377 | Upgrade
|
Long-Term Debt Repaid | - | -5.52 | -3.36 | -5.07 | -3.32 | - | Upgrade
|
Total Debt Repaid | -455.22 | -406.52 | -383.5 | -251.07 | -616.32 | -377 | Upgrade
|
Net Debt Issued (Repaid) | 53.16 | 139.56 | -42.5 | 125.68 | -220.32 | 443 | Upgrade
|
Issuance of Common Stock | - | - | 30.59 | - | - | 20 | Upgrade
|
Repurchase of Common Stock | - | - | - | - | - | -83.94 | Upgrade
|
Common Dividends Paid | -7.63 | -8.42 | -70.1 | -4.73 | -114.92 | -41.58 | Upgrade
|
Other Financing Activities | -119.82 | 10 | -84 | -130.33 | -0.01 | 1 | Upgrade
|
Financing Cash Flow | -74.3 | 141.14 | -166.01 | -9.37 | -335.25 | 338.47 | Upgrade
|
Foreign Exchange Rate Adjustments | -1.67 | -6.41 | 0.2 | 18.3 | -2.98 | -9.01 | Upgrade
|
Net Cash Flow | 27.73 | -20.73 | -122.3 | 31.37 | -278.72 | -434.68 | Upgrade
|
Free Cash Flow | -21.72 | -28.91 | -89.77 | 107.53 | -256.65 | -482.4 | Upgrade
|
Free Cash Flow Margin | -1.78% | -2.54% | -5.03% | 5.75% | -11.48% | -20.25% | Upgrade
|
Free Cash Flow Per Share | -0.01 | -0.01 | -0.04 | 0.05 | -0.12 | -0.23 | Upgrade
|
Cash Income Tax Paid | - | -95.07 | -86.11 | -3.22 | 70.54 | 89.72 | Upgrade
|
Levered Free Cash Flow | 153.97 | -3.53 | 15.77 | 36.83 | -65.62 | -338.68 | Upgrade
|
Unlevered Free Cash Flow | 153.97 | -8.95 | 19.94 | 40.48 | -59.82 | -329.09 | Upgrade
|
Change in Net Working Capital | -166.45 | -42.2 | -160.45 | -48.02 | -168.71 | -9.58 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.